NICE guidance on the prevention and management of neutropenic sepsis in cancer patients (CG151)
This NICE guidance outlines recommendations for the prevention, identification and management of neutropenic sepsis in people with cancer.
This NICE guidance outlines recommendations for the prevention, identification and management of neutropenic sepsis in people with cancer.
This paper, written by an expert panel of the International Myeloma Working Group, examines the impact of novel treatments on stem cell collection in myeloma patients. It summarises the available evidence and makes recommendations to address identified issues.
Following consultation on the scope of the guideline we have decided to retain Improving supportive and palliative care for adults with cancer. The title of the new guideline will be changed to End of life care for adults in the last year of life: service delivery. Where there is overlap between the two guidelines we…
Details